Correlation Between Agilent Technologies and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Agilent Technologies and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Agilent Technologies and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Agilent Technologies and ProQR Therapeutics BV, you can compare the effects of market volatilities on Agilent Technologies and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Agilent Technologies with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Agilent Technologies and ProQR Therapeutics.
Diversification Opportunities for Agilent Technologies and ProQR Therapeutics
-0.68 | Correlation Coefficient |
Excellent diversification
The 3 months correlation between Agilent and ProQR is -0.68. Overlapping area represents the amount of risk that can be diversified away by holding Agilent Technologies and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Agilent Technologies is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Agilent Technologies are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Agilent Technologies i.e., Agilent Technologies and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Agilent Technologies and ProQR Therapeutics
Taking into account the 90-day investment horizon Agilent Technologies is expected to generate 6.18 times less return on investment than ProQR Therapeutics. But when comparing it to its historical volatility, Agilent Technologies is 4.55 times less risky than ProQR Therapeutics. It trades about 0.04 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 176.00 in ProQR Therapeutics BV on August 31, 2024 and sell it today you would earn a total of 208.00 from holding ProQR Therapeutics BV or generate 118.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Agilent Technologies vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Agilent Technologies |
| ProQR Therapeutics |
Agilent Technologies and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Agilent Technologies and ProQR Therapeutics
The main advantage of trading using opposite Agilent Technologies and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Agilent Technologies position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Agilent Technologies vs. IDEXX Laboratories | Agilent Technologies vs. IQVIA Holdings | Agilent Technologies vs. Charles River Laboratories | Agilent Technologies vs. Revvity |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Economic Indicators Top statistical indicators that provide insights into how an economy is performing | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Money Managers Screen money managers from public funds and ETFs managed around the world |